Related Experiment Video
Updated: May 22, 2026

A High-Throughput Comet Assay Approach for Assessing Cellular DNA Damage
Published on: May 10, 2022
Depletion of p31comet protein promotes sensitivity to antimitotic drugs
Hoi Tang Ma1, Yan Yan Chan, Xiao Chen
1Division of Life Science and Center for Cancer Research, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong.
Abstract:
Antimitotic spindle poisons are among the most important chemotherapeutic agents available. However, precocious mitotic exit by mitotic slippage limits the cytotoxicity of spindle poisons. The MAD2-binding protein p31(comet) is implicated in silencing the spindle assembly checkpoint after all kinetochores are attached to spindles. In this study, we report that the levels of p31(comet) and MAD2 in different cell lines are closely linked with susceptibility to mitotic slippage. Down-regulation of p31(comet) increased the sensitivity of multiple cancer cell lines to spindle poisons, including nocodazole, vincristine, and Taxol. In the absence of p31(comet), lower concentrations of spindle poisons were required to induce mitotic block. The delay in checkpoint silencing was induced by an accumulation of mitotic checkpoint complexes. The increase in the duration of mitotic block after p31(comet) depletion resulted in a dramatic increase in mitotic cell death upon challenge with spindle poisons. Significantly, cells that are normally prone to mitotic slippage and resistant to spindle disruption-mediated mitotic death were also sensitized after p31(comet) depletion. These results highlight the importance of p31(comet) in checkpoint silencing and its potential as a target for antimitotic therapies.
Insights
Down-regulating p31(comet) enhances cancer cell sensitivity to antimitotic drugs by delaying mitotic exit. This highlights p31(comet) as a potential therapeutic target to improve chemotherapy efficacy.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Therapeutics
Background:
- Antimitotic spindle poisons are crucial chemotherapeutics, but their efficacy is limited by mitotic slippage.
- Mitotic slippage, or premature mitotic exit, reduces cancer cell death induced by spindle poisons.
- p31(comet), a MAD2-binding protein, plays a role in silencing the spindle assembly checkpoint.
Purpose of the Study:
- To investigate the role of p31(comet) in mitotic slippage and sensitivity to spindle poisons.
- To determine if targeting p31(comet) can enhance the cytotoxicity of antimitotic agents.
Main Methods:
- Analysis of p31(comet) and MAD2 levels in various cell lines.
- Down-regulation of p31(comet) using genetic manipulation.
- Treatment of cancer cell lines with spindle poisons (nocodazole, vincristine, Taxol).
- Assessment of mitotic block duration, mitotic cell death, and cell sensitivity.
Main Results:
- p31(comet) and MAD2 levels correlated with susceptibility to mitotic slippage.
- Down-regulation of p31(comet) significantly increased cancer cell sensitivity to multiple spindle poisons.
- Reduced p31(comet) levels led to prolonged mitotic arrest and increased mitotic cell death.
- Cells resistant to spindle poisons were sensitized upon p31(comet) depletion.
Conclusions:
- p31(comet) is critical for efficient spindle assembly checkpoint silencing.
- Depleting p31(comet) enhances antimitotic drug efficacy by preventing mitotic slippage.
- p31(comet) represents a promising therapeutic target for improving antimitotic cancer treatments.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules

